UPDATE: JPMorgan Starts Verve Therapeutics (VERV) at Neutral
Tweet Send to a Friend
(Updated - July 12, 2021 1:30 AM EDT)
JPMorgan analyst Eric Joseph initiates coverage on Verve Therapeutics (NASDAQ: VERV) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph initiates coverage on Verve Therapeutics (NASDAQ: VERV) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
